CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

HER2-low breast cancer (IHC 1+ or IHC 2+/ISH-)

Gene: ERBB2 · Type: expression

Indications: Breast cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
Fam-trastuzumab deruxtecanBreast cancerINDICATED
FDA Label
Label